LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 50

Search options

  1. Article ; Online: Latent Tuberculosis Infection Treatment: Compliance and Factors Related with Initiation.

    Gullón Blanco, José Antonio / Rodrigo Sanz, Teresa / Álvarez Navascues, Fernando / Tabernero Huguet, Eva / Sabría Mestres, Josefina / García García, José María

    Archivos de bronconeumologia

    2022  Volume 59, Issue 5, Page(s) 334–336

    MeSH term(s) Humans ; Latent Tuberculosis/drug therapy ; Tuberculin Test ; Antitubercular Agents/therapeutic use ; Patient Compliance
    Chemical Substances Antitubercular Agents
    Language Spanish
    Publishing date 2022-12-23
    Publishing country Spain
    Document type Case Reports
    ZDB-ID 733126-5
    ISSN 1579-2129 ; 0300-2896
    ISSN (online) 1579-2129
    ISSN 0300-2896
    DOI 10.1016/j.arbres.2022.12.011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Drug Resistant Tuberculosis: New WHO Definitions and Their Implication in the SEPAR Guideline.

    Caminero, José A / García-García, José-María / Cayla, Joan A / García-Pérez, Francisco J / Palacios, Juan J / Ruiz-Manzano, Juan

    Archivos de bronconeumologia

    2021  Volume 58, Issue 1, Page(s) 87–89

    Title translation Tuberculosis con resistencia a fármacos: nuevas definiciones de la OMS y su implicación en la Normativa de SEPAR.
    Language Spanish
    Publishing date 2021-03-08
    Publishing country Spain
    Document type Case Reports
    ZDB-ID 733126-5
    ISSN 1579-2129 ; 0300-2896
    ISSN (online) 1579-2129
    ISSN 0300-2896
    DOI 10.1016/j.arbres.2021.03.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Tuberculosis contacts study: Organization and prevalence of latent tuberculosis infection.

    Gullón Blanco, José Antonio / Rodrigo Sanz, Teresa / Álvarez Navascues, Fernando / Tabernero Huguet, Eva / Sabría Mestres, Josefina / García-García, José-María

    Archivos de bronconeumologia

    2021  Volume 57, Issue 7, Page(s) 509–511

    MeSH term(s) Contact Tracing ; Humans ; Latent Tuberculosis/epidemiology ; Mycobacterium tuberculosis ; Prevalence ; Tuberculin Test
    Language English
    Publishing date 2021-05-18
    Publishing country Spain
    Document type Case Reports
    ZDB-ID 733126-5
    ISSN 1579-2129 ; 0300-2896
    ISSN (online) 1579-2129
    ISSN 0300-2896
    DOI 10.1016/j.arbr.2021.05.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Guidelines for the use of interferon-γ release assays in the diagnosis of tuberculosis infection.

    Santin, Miguel / García-García, José-María / Domínguez, José

    Enfermedades infecciosas y microbiologia clinica

    2016  Volume 34, Issue 5, Page(s) 303.e1–13

    Abstract: Introduction: Interferon-gamma release assays are widely used for the diagnosis of tuberculosis infection in low-prevalence countries. However, there is no consensus on their application. The objective of this study was to develop guidelines for the use ...

    Abstract Introduction: Interferon-gamma release assays are widely used for the diagnosis of tuberculosis infection in low-prevalence countries. However, there is no consensus on their application. The objective of this study was to develop guidelines for the use of interferon-gamma release assays in specific clinical scenarios in Spain.
    Methods: A panel of experts comprising specialists in infectious diseases, respiratory diseases, microbiology, pediatrics and preventive medicine, together with a methodologist, formulated the clinical questions and outcomes of interest. They conducted a systematic literature search, summarized the evidence and rated its quality, and prepared the recommendations following the GRADE (Grading of Recommendations of Assessment Development and Evaluations) methodology.
    Results: The panel prepared recommendations on the use of interferon-gamma release assays for the diagnosis of tuberculosis infection in the contact-tracing study (both adults and children), health care workers, immunosuppressed patients (patients infected with human immunodeficiency virus, patients with chronic immunomediated inflammatory diseases due to start biological therapy and patients requiring organ transplant) and for the diagnosis of active tuberculosis. Most recommendations were weak, mainly due to the lack of good quality evidence to balance the clinical benefits and disadvantages of the interferon-gamma release assays as compared with the tuberculin skin test.
    Conclusion: This document provides evidence-based guidance on the use of interferon-gamma release assays for the diagnosis of tuberculosis infection in patients at risk of tuberculosis or with suspicion of active disease. The guidelines will be applicable in specialist and primary care and in public health settings.
    MeSH term(s) Humans ; Interferon-gamma Release Tests/standards ; Practice Guidelines as Topic ; Spain ; Tuberculin Test ; Tuberculosis/diagnosis
    Language English
    Publishing date 2016-05
    Publishing country Spain
    Document type Journal Article
    ZDB-ID 1070941-1
    ISSN 1578-1852 ; 0213-005X
    ISSN (online) 1578-1852
    ISSN 0213-005X
    DOI 10.1016/j.eimc.2015.11.022
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Dosis de protionamida y PAS. Corrección al «Documento de Consenso sobre diagnóstico, tratamiento y prevención de la tuberculosis».

    García-García, José-María / González-Martín, Julià

    Enfermedades infecciosas y microbiologia clinica

    2015  Volume 34, Issue 7, Page(s) 466

    Title translation Prothionamide and PAS doses. Correction to «Consensus document on the diagnosis, treatment and prevention of tuberculosis».
    MeSH term(s) Antitubercular Agents ; Consensus ; Humans ; Prothionamide ; Tuberculosis
    Chemical Substances Antitubercular Agents ; Prothionamide (76YOO33643)
    Language Spanish
    Publishing date 2015-08-19
    Publishing country Spain
    Document type Letter ; Comment
    ZDB-ID 1070941-1
    ISSN 1578-1852 ; 0213-005X
    ISSN (online) 1578-1852
    ISSN 0213-005X
    DOI 10.1016/j.eimc.2015.07.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Breathing Back Better! A State of the Art on the Benefits of Functional Evaluation and Rehabilitation of Post-Tuberculosis and Post-COVID Lungs.

    Pontali, Emanuele / Silva, Denise Rossato / Marx, Florian M / Caminero, Jose Antonio / Centis, Rosella / D'Ambrosio, Lia / Garcia-Garcia, Jose Maria / Muhwa, Jeremiah Chakaya / Tiberi, Simon / Migliori, Giovanni Battista

    Archivos de bronconeumologia

    2022  Volume 58, Issue 11, Page(s) 754–763

    Abstract: Currently, tuberculosis (TB) and COVID-19 account for substantial morbidity and mortality worldwide, not only during their acute phase, but also because of their sequelae. This scoping review aims to describe the specific aspects of post-TB and post- ... ...

    Abstract Currently, tuberculosis (TB) and COVID-19 account for substantial morbidity and mortality worldwide, not only during their acute phase, but also because of their sequelae. This scoping review aims to describe the specific aspects of post-TB and post-COVID (long-COVID-19) sequelae, and the implications for post-disease follow-up and rehabilitation. In particular, evidence on how to identify patients affected by sequelae is presented and discussed. A section of the review is dedicated to identifying patients eligible for pulmonary rehabilitation (PR), as not all patients with sequelae are eligible for PR. Components of PR are presented and discussed, as well as their effectiveness. Other essential components to implement comprehensive rehabilitation programmes such as counselling and health education of enrolled patients, evaluation of cost-effectiveness of PR and its impact on health systems as well as research priorities for the future are included in this scoping review.
    MeSH term(s) Humans ; COVID-19 ; Tuberculosis ; Cost-Benefit Analysis ; Lung ; Post-Acute COVID-19 Syndrome
    Language Spanish
    Publishing date 2022-06-10
    Publishing country Spain
    Document type Journal Article ; Review
    ZDB-ID 733126-5
    ISSN 1579-2129 ; 0300-2896
    ISSN (online) 1579-2129
    ISSN 0300-2896
    DOI 10.1016/j.arbres.2022.05.010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Non-Tuberculous Mycobacterial Diseases in Spain: Treatment and Evolution.

    Villanueva-Montes, Manuel Ángel / Álvarez Navascués, Fernando / Gullón Blanco, José Antonio / Rodrigo Sanz, Teresa / Medina Gallardo, Juan Francisco / Caminero Luna, José Antonio / García-García, José María

    Archivos de bronconeumologia

    2022  Volume 58, Issue 5, Page(s) 457–460

    Title translation Enfermedades por micobacterias no tuberculosas en España: tratamiento y evolución.
    MeSH term(s) Humans ; Mycobacterium Infections, Nontuberculous/drug therapy ; Mycobacterium Infections, Nontuberculous/epidemiology ; Nontuberculous Mycobacteria ; Spain/epidemiology
    Language Spanish
    Publishing date 2022-02-17
    Publishing country Spain
    Document type Case Reports
    ZDB-ID 733126-5
    ISSN 1579-2129 ; 0300-2896
    ISSN (online) 1579-2129
    ISSN 0300-2896
    DOI 10.1016/j.arbres.2022.01.017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Corrigendum: consensus document on the diagnosis, treatment and prevention of tuberculosis. prothionamide and PAS doses.

    García-García, José-María / González-Martín, Julià

    Archivos de bronconeumologia

    2015  Volume 51, Issue 10, Page(s) 533

    Language Spanish
    Publishing date 2015-10
    Publishing country Spain
    Document type Published Erratum
    ZDB-ID 733126-5
    ISSN 1579-2129 ; 0300-2896
    ISSN (online) 1579-2129
    ISSN 0300-2896
    DOI 10.1016/j.arbres.2015.07.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Diagnosis of Tuberculous Infection in Immunosuppressed Patients and/or Candidates for Biologics Using a Combination of 2 IGRA Tests: T-SPOT.TB/QuantiFERON TB Gold In-Tube vs. T-SPOT.TB/QuantiFERON TB Gold Plus.

    Fernández-Blázquez, Ana / Argüelles Menéndez, Pablo / Sabater-Cabrera, Christian / García-García, José-María / Asensi Álvarez, Víctor / Palacios Gutiérrez, Juan José

    Archivos de bronconeumologia

    2020  Volume 58, Issue 4, Page(s) 305–310

    Abstract: Introduction: The diagnosis of latent tuberculous infection (LTI) by IGRA continues to generate debate. Experience in the simultaneous use of 2 IGRA tests is scant. The aim of this study was to compare the results of 2 versions of QuantiFERON-TB Gold ( ... ...

    Title translation Diagnóstico de la infección tuberculosa en pacientes inmunodeprimidos y/o candidatos a terapias biológicas mediante el uso combinado de dos pruebas IGRA: T-SPOT.TB/QuantiFERON TB Gold In-Tube vs. T-SPOT.TB/QuantiFERON TB Gold Plus.
    Abstract Introduction: The diagnosis of latent tuberculous infection (LTI) by IGRA continues to generate debate. Experience in the simultaneous use of 2 IGRA tests is scant. The aim of this study was to compare the results of 2 versions of QuantiFERON-TB Gold (In-Tube/Plus) with those of T-SPOT.TB, and to analyse the effectiveness of a dual strategy (T-SPOT.TB + QTF) for the diagnosis of LTI in an immunosuppressed population.
    Methods: We conducted a prospective study (May 2015-June 2017) that included 2,999 immunosuppressed patients and/or candidates for biologics, in whom 2 simultaneous IGRA tests were performed: Group 1 (1535 patients): T-SPOT.TB + QuantiFERON-TB Gold-In-Tube (QTF-GIT); Group 2 (1464 patients): T-SPOT.TB + QuantiFERON-TB Gold Plus (QTF-Plus).
    Results: The concordance between QTF-GIT and T-SPOT.TB was 83.19% (κ=0.532). The percentage of positive, negative, and indeterminate results were, respectively: 14.33% vs. 17.06%; 82.41% vs. 74.46%; and 3.25% vs. 8.46%. The concordance between QTF-Plus and T-SPOT.TB was 87.56% (κ=0.609). The percentage of positive, negative, and indeterminate results were, respectively: 15.02% vs. 15.36%; 82.92% vs. 79.37%; and 2.04% vs. 5.25%. Discrepancies between T-SPOT.TB and QTF-Plus were 12.43%, suggesting that 103 patients were positive and another 79 were negative due exclusively to 1 of the 2 IGRAs.
    Conclusions: Greater concordance was found between QTF-Plus and T-SPOT.TB than between QTF-GIT and T-SPOT.TB. However, we believe that the proportion of discrepancies between T-SPOT.TB and QTF-Plus is sufficiently important from a clinical point of view to justify the simultaneous use of 2 IGRA in this specific patient group.
    MeSH term(s) Biological Products ; Humans ; Interferon-gamma Release Tests ; Latent Tuberculosis/diagnosis ; Prospective Studies ; Tuberculin Test/methods ; Tuberculosis/diagnosis
    Chemical Substances Biological Products
    Language Spanish
    Publishing date 2020-06-10
    Publishing country Spain
    Document type Journal Article
    ZDB-ID 733126-5
    ISSN 1579-2129 ; 0300-2896
    ISSN (online) 1579-2129
    ISSN 0300-2896
    DOI 10.1016/j.arbres.2020.04.011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Tuberculosis Contacts Study: Organization and Prevalence of Latent Tuberculosis Infection.

    Gullón Blanco, José Antonio / Rodrigo Sanz, Teresa / Álvarez Navascues, Fernando / Tabernero Huguet, Eva / Sabría Mestres, Josefina / García-García, José-María

    Archivos de bronconeumologia

    2020  

    Title translation Estudio de contactos de pacientes con tuberculosis: organización y prevalencia de la infección tuberculosa latente.
    Language Spanish
    Publishing date 2020-12-31
    Publishing country Spain
    Document type Case Reports
    ZDB-ID 2591346-3
    ISSN 2173-5751 ; 2173-5751
    ISSN (online) 2173-5751
    ISSN 2173-5751
    DOI 10.1016/j.arbres.2020.12.021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top